Free Trial

Oxford Nanopore Technologies (ONT) Competitors

GBX 107.30
+2.10 (+2.00%)
(As of 05/31/2024 ET)

ONT vs. BTG, ABC, GNS, ERGO, PRTC, SLN, OXB, HZD, VRP, and BVXP

Should you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include BTG (BTG), Abcam (ABC), Genus (GNS), Ergomed (ERGO), PureTech Health (PRTC), Silence Therapeutics (SLN), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), and Bioventix (BVXP). These companies are all part of the "biotechnology" industry.

Oxford Nanopore Technologies vs.

BTG (LON:BTG) and Oxford Nanopore Technologies (LON:ONT) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, community ranking, profitability, institutional ownership, earnings and valuation.

BTG has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BTG£914.10M0.00N/A£28.50N/A
Oxford Nanopore Technologies£169.67M5.46-£154.51M-£0.19-564.74

In the previous week, BTG had 4 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 4 mentions for BTG and 0 mentions for Oxford Nanopore Technologies. Oxford Nanopore Technologies' average media sentiment score of 0.04 beat BTG's score of 0.00 indicating that BTG is being referred to more favorably in the media.

Company Overall Sentiment
BTG Neutral
Oxford Nanopore Technologies Neutral

BTG has a net margin of 0.00% compared to BTG's net margin of -91.06%. Oxford Nanopore Technologies' return on equity of 0.00% beat BTG's return on equity.

Company Net Margins Return on Equity Return on Assets
BTGN/A N/A N/A
Oxford Nanopore Technologies -91.06%-23.10%-13.17%

38.6% of Oxford Nanopore Technologies shares are held by institutional investors. 30.0% of Oxford Nanopore Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Oxford Nanopore Technologies has a consensus price target of GBX 303.75, suggesting a potential upside of 183.08%.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BTG
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Oxford Nanopore Technologies
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

BTG received 591 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 73.95% of users gave BTG an outperform vote.

CompanyUnderperformOutperform
BTGOutperform Votes
619
73.95%
Underperform Votes
218
26.05%
Oxford Nanopore TechnologiesOutperform Votes
28
100.00%
Underperform Votes
No Votes

Summary

BTG beats Oxford Nanopore Technologies on 9 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONT vs. The Competition

MetricOxford Nanopore TechnologiesBiotechnology IndustryMedical SectorLON Exchange
Market Cap£925.56M£137.64M£5.12B£1.66B
Dividend YieldN/A3.49%2.75%6.87%
P/E Ratio-564.74201.85159.551,934.41
Price / Sales5.4619,056.502,430.65346,599.15
Price / Cash4.0411.5935.2026.25
Price / Book1.437.165.532.95
Net Income-£154.51M-£20.65M£106.01M£165.02M
7 Day Performance-2.72%1.20%1.14%0.17%
1 Month Performance6.03%5.07%1.43%6.59%
1 Year Performance-60.11%6.28%4.07%17.30%

Oxford Nanopore Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTG
BTG
0 of 5 stars
GBX 840
+0.1%
N/A+0.0%£3.26B£914.10M29.471,631
ABC
Abcam
0 of 5 stars
GBX 1,226
+11.2%
N/AN/A£2.81B£350.40M20,433.331,650Gap Up
High Trading Volume
GNS
Genus
0 of 5 stars
GBX 1,816
+1.1%
N/A-28.7%£1.20B£673.10M3,560.783,500
ERGO
Ergomed
0 of 5 stars
GBX 1,346
flat
GBX 1,400
+4.0%
+32.7%£701.00M£152.09M4,641.381,400
PRTC
PureTech Health
0 of 5 stars
GBX 226
-0.7%
N/A+4.2%£611.13M£3.33M-1,189.47300
SLN
Silence Therapeutics
0 of 5 stars
GBX 535
-0.9%
N/A+0.0%£480.35M£11.35M-11.0174High Trading Volume
OXB
Oxford Biomedica
1.7373 of 5 stars
GBX 315.47
+0.1%
GBX 431.25
+36.7%
-26.4%£315.47M£89.54M-193.54891Gap Up
HZD
Horizon Discovery Group plc (HZD.L)
0 of 5 stars
GBX 184.50
flat
N/A+0.0%£302.98M£54.63M-33.55416
VRP
Verona Pharma plc (VRP.L)
0 of 5 stars
GBX 55
+5.8%
N/A+0.0%£228MN/A-1.6822Gap Up
BVXP
Bioventix
0 of 5 stars
GBX 4,325
+0.6%
N/A+16.4%£225.77M£13.60M2,653.3712

Related Companies and Tools

This page (LON:ONT) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners